Compare Mirae Asset Healthcare Fund vs SBI Healthcare Opportunities Fund
Mirae Asset Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹99
₹500
Expense Ratio
2.04
1.99
NAV
₹49.19
₹559.17
Fund Started
11 Jun 2018
04 Jun 1999
Fund Size
₹3494.44 Cr
₹5870.00 Cr
Exit Load
Exit load of 1% if redeemed within 1 Month.
Exit load of 0.50% if redeemed within 15 days
1 Year
10.80%
9.93%
3 Year
19.10%
20.31%
5 Year
13.11%
16.00%
Equity
99.97%
95.53%
Cash
0.03%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.15% |
Divi's Laboratories Ltd. | 9.79% |
Torrent Pharmaceuticals Ltd. | 6.80% |
Apollo Hospitals Enterprise Ltd. | 5.62% |
Laurus Labs Ltd. | 5.51% |
Dr. Reddy's Laboratories Ltd. | 4.84% |
Glenmark Pharmaceuticals Ltd. | 4.78% |
Aurobindo Pharma Ltd. | 3.78% |
Alkem Laboratories Ltd. | 3.76% |
Ipca Laboratories Ltd. | 3.39% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate long term capital appreciation through investing in equity and equity related securities of companies/Entities benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
11 Jun 2018
04 Jun 1999
